SHARPIN is a key regulator of immune and inflammatory responses

Zhe Wang, Christopher S. Potter, John P. Sundberg, Harm HogenEsch

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Mice with spontaneous mutations in the Sharpin gene develop chronic proliferative dermatitis that is characterized by eosinophilic inflammation of the skin and other organs with increased expression of type 2 cytokines and dysregulated development of lymphoid tissues. The mutant mice share phenotypic features with human hypereosinophilic syndromes. The biological function of SHARPIN and how its absence leads to such a complex inflammatory phenotype in mice are poorly understood. However, recent studies identified SHARPIN as a novel modulator of immune and inflammatory responses. The emerging mechanistic model suggests that SHARPIN functions as an important adaptor component of the linear ubiquitin chain assembly complex that modulates activation of NF-κB signalling pathway, thereby regulating cell survival and apoptosis, cytokine production and development of lymphoid tissues. In this review, we will summarize the current understanding of the ubiquitin-dependent regulatory mechanisms involved in NF-κB signalling, and incorporate the recently obtained molecular insights of SHARPIN into this pathway. Recent studies identified SHARPIN as an inhibitor of β1-integrin activation and signalling, and this may be another mechanism by which SHARPIN regulates inflammation. Furthermore, the disrupted lymphoid organogenesis in SHARPIN-deficient mice suggests that SHARPIN-mediated NF-κB regulation is important for de novo development of lymphoid tissues.

Original languageEnglish (US)
Pages (from-to)2271-2279
Number of pages9
JournalJournal of Cellular and Molecular Medicine
Volume16
Issue number10
DOIs
StatePublished - Oct 2012
Externally publishedYes

Fingerprint

Lymphoid Tissue
Ubiquitin
Cytokines
Hypereosinophilic Syndrome
Inflammation
Organogenesis
Dermatitis
Integrins
Cell Survival
Apoptosis
Phenotype
Skin
Mutation
Genes

Keywords

  • Chronic dermatitis
  • Eosinophilic dermatitis
  • Immune system
  • Inflammation
  • Lymphoid organogenesis
  • NF-κB
  • Scaly skin disease
  • Sharpin
  • Ubiquitination

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Medicine

Cite this

SHARPIN is a key regulator of immune and inflammatory responses. / Wang, Zhe; Potter, Christopher S.; Sundberg, John P.; HogenEsch, Harm.

In: Journal of Cellular and Molecular Medicine, Vol. 16, No. 10, 10.2012, p. 2271-2279.

Research output: Contribution to journalArticle

Wang, Zhe ; Potter, Christopher S. ; Sundberg, John P. ; HogenEsch, Harm. / SHARPIN is a key regulator of immune and inflammatory responses. In: Journal of Cellular and Molecular Medicine. 2012 ; Vol. 16, No. 10. pp. 2271-2279.
@article{74306817c16b458b81963a9770887dc9,
title = "SHARPIN is a key regulator of immune and inflammatory responses",
abstract = "Mice with spontaneous mutations in the Sharpin gene develop chronic proliferative dermatitis that is characterized by eosinophilic inflammation of the skin and other organs with increased expression of type 2 cytokines and dysregulated development of lymphoid tissues. The mutant mice share phenotypic features with human hypereosinophilic syndromes. The biological function of SHARPIN and how its absence leads to such a complex inflammatory phenotype in mice are poorly understood. However, recent studies identified SHARPIN as a novel modulator of immune and inflammatory responses. The emerging mechanistic model suggests that SHARPIN functions as an important adaptor component of the linear ubiquitin chain assembly complex that modulates activation of NF-κB signalling pathway, thereby regulating cell survival and apoptosis, cytokine production and development of lymphoid tissues. In this review, we will summarize the current understanding of the ubiquitin-dependent regulatory mechanisms involved in NF-κB signalling, and incorporate the recently obtained molecular insights of SHARPIN into this pathway. Recent studies identified SHARPIN as an inhibitor of β1-integrin activation and signalling, and this may be another mechanism by which SHARPIN regulates inflammation. Furthermore, the disrupted lymphoid organogenesis in SHARPIN-deficient mice suggests that SHARPIN-mediated NF-κB regulation is important for de novo development of lymphoid tissues.",
keywords = "Chronic dermatitis, Eosinophilic dermatitis, Immune system, Inflammation, Lymphoid organogenesis, NF-κB, Scaly skin disease, Sharpin, Ubiquitination",
author = "Zhe Wang and Potter, {Christopher S.} and Sundberg, {John P.} and Harm HogenEsch",
year = "2012",
month = "10",
doi = "10.1111/j.1582-4934.2012.01574.x",
language = "English (US)",
volume = "16",
pages = "2271--2279",
journal = "Journal of Cellular and Molecular Medicine",
issn = "1582-1838",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - SHARPIN is a key regulator of immune and inflammatory responses

AU - Wang, Zhe

AU - Potter, Christopher S.

AU - Sundberg, John P.

AU - HogenEsch, Harm

PY - 2012/10

Y1 - 2012/10

N2 - Mice with spontaneous mutations in the Sharpin gene develop chronic proliferative dermatitis that is characterized by eosinophilic inflammation of the skin and other organs with increased expression of type 2 cytokines and dysregulated development of lymphoid tissues. The mutant mice share phenotypic features with human hypereosinophilic syndromes. The biological function of SHARPIN and how its absence leads to such a complex inflammatory phenotype in mice are poorly understood. However, recent studies identified SHARPIN as a novel modulator of immune and inflammatory responses. The emerging mechanistic model suggests that SHARPIN functions as an important adaptor component of the linear ubiquitin chain assembly complex that modulates activation of NF-κB signalling pathway, thereby regulating cell survival and apoptosis, cytokine production and development of lymphoid tissues. In this review, we will summarize the current understanding of the ubiquitin-dependent regulatory mechanisms involved in NF-κB signalling, and incorporate the recently obtained molecular insights of SHARPIN into this pathway. Recent studies identified SHARPIN as an inhibitor of β1-integrin activation and signalling, and this may be another mechanism by which SHARPIN regulates inflammation. Furthermore, the disrupted lymphoid organogenesis in SHARPIN-deficient mice suggests that SHARPIN-mediated NF-κB regulation is important for de novo development of lymphoid tissues.

AB - Mice with spontaneous mutations in the Sharpin gene develop chronic proliferative dermatitis that is characterized by eosinophilic inflammation of the skin and other organs with increased expression of type 2 cytokines and dysregulated development of lymphoid tissues. The mutant mice share phenotypic features with human hypereosinophilic syndromes. The biological function of SHARPIN and how its absence leads to such a complex inflammatory phenotype in mice are poorly understood. However, recent studies identified SHARPIN as a novel modulator of immune and inflammatory responses. The emerging mechanistic model suggests that SHARPIN functions as an important adaptor component of the linear ubiquitin chain assembly complex that modulates activation of NF-κB signalling pathway, thereby regulating cell survival and apoptosis, cytokine production and development of lymphoid tissues. In this review, we will summarize the current understanding of the ubiquitin-dependent regulatory mechanisms involved in NF-κB signalling, and incorporate the recently obtained molecular insights of SHARPIN into this pathway. Recent studies identified SHARPIN as an inhibitor of β1-integrin activation and signalling, and this may be another mechanism by which SHARPIN regulates inflammation. Furthermore, the disrupted lymphoid organogenesis in SHARPIN-deficient mice suggests that SHARPIN-mediated NF-κB regulation is important for de novo development of lymphoid tissues.

KW - Chronic dermatitis

KW - Eosinophilic dermatitis

KW - Immune system

KW - Inflammation

KW - Lymphoid organogenesis

KW - NF-κB

KW - Scaly skin disease

KW - Sharpin

KW - Ubiquitination

UR - http://www.scopus.com/inward/record.url?scp=84866397566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866397566&partnerID=8YFLogxK

U2 - 10.1111/j.1582-4934.2012.01574.x

DO - 10.1111/j.1582-4934.2012.01574.x

M3 - Article

VL - 16

SP - 2271

EP - 2279

JO - Journal of Cellular and Molecular Medicine

JF - Journal of Cellular and Molecular Medicine

SN - 1582-1838

IS - 10

ER -